Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | completed | Phase 1 | 63 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00508807 | RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies | completed | Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00006354 |
| Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy |
| completed |
| Phase 1 |
| 41 |
| European Organisation for Research and Treatment of Cancer - EORTCNETWORK |
| 2 |
| Jul 24, 2012 |
| clinicaltrials |
| NCT00027677 | Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 24, 2012 | clinicaltrials |
| NCT01170975 | Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules | completed | Phase 1 | 12 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT01315431 | A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors | unknown | Phase 1 | 9 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00874042 | Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 74 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Jul 23, 2012 | clinicaltrials |
| NCT00591136 | Phase I Study of Indibulin in Patients With Solid Tumors | completed | Phase 1 | 47 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00591396 | A Phase I Trial of ZIO-101 in Solid Tumors | completed | Phase 1 | 40 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT01139346 | Study of Oral Darinaparsin in Patients With Advanced Solid Tumors | completed | Phase 1 | 12 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 19, 2012 | clinicaltrials |
| NCT00005061 | Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 20 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jul 18, 2012 | clinicaltrials |
| NCT00006477 | Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors | completed | Phase 1 | 26 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Jul 18, 2012 | clinicaltrials |
| NCT00793897 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 21 | Bristol-Myers SquibbINDUSTRY | 3 | Jul 13, 2012 | clinicaltrials |
| NCT00003213 | Drugs to Reduce the Side Effects of Chemotherapy | completed | Phase 3 | 267 | Swiss Cancer InstituteOTHER | 2 | Jul 11, 2012 | clinicaltrials |
| NCT00003976 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003980 | BIBX 1382 in Treating Patients With Solid Tumors | suspended | Phase 1 | 80 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003981 | E7070 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003982 | MEN-10755 in Treating Patients With Solid Tumors | completed | Phase 1 | 30 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003985 | KRN7000 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00731263 | A Study of Tor Kinase Inhibitor in Advanced Tumors | completed | Phase 1 | 64 | AstraZenecaINDUSTRY | 3 | Jul 11, 2012 | clinicaltrials |
| NCT00608738 | Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment | completed | N/A | 750 | Northwestern UniversityOTHER | 0 | Jul 10, 2012 | clinicaltrials |
| NCT00002904 | Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors | completed | Phase 1 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003028 | MEN-10755 in Treating Adults With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 5 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Jul 2, 2012 | clinicaltrials |
| NCT00003721 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 33 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 29, 2012 | clinicaltrials |
| NCT00003706 | LY231514 in Treating Patients With Locally Advanced or Metastatic Solid Tumors and Varying Degrees of Kidney Function | completed | Phase 1 | 50 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00003707 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 22 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01226901 | A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) | terminated | Phase 1 | 3 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 28, 2012 | clinicaltrials |
| NCT00424632 | Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors | completed | Phase 1 | 57 | PfizerINDUSTRY | 2 | Jun 25, 2012 | clinicaltrials |
| NCT00886496 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00086723 | In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00004914 | Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT01247168 | An Open-Label, Dose-Escalation Study of AZD2461 | completed | Phase 1 | 75 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00004912 | Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | May 30, 2012 | clinicaltrials |
| NCT00237627 | Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT00415376 | Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases | withdrawn | N/A | 0 | Northwestern UniversityOTHER | 0 | May 18, 2012 | clinicaltrials |
| NCT00004212 | DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00077077 | DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00320073 | Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 41 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00586560 | Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)(KTN10010) | completed | Phase 1 | 15 | Baylor College of MedicineOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00839631 | Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors | completed | Phase 1 | 23 | DendreonINDUSTRY | 1 | May 2, 2012 | clinicaltrials |
| NCT01147029 | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | terminated | Phase 1 | 35 | Cancer Research UKOTHER | 1 | May 1, 2012 | clinicaltrials |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | withdrawn | Phase 1 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 25, 2012 | clinicaltrials |
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 31 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00741234 | A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine | completed | Phase 1 | 85 | S*BIOINDUSTRY | 2 | Apr 23, 2012 | clinicaltrials |
| NCT00389922 | Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | University of California, DavisOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01106248 | QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors | completed | Phase 1 | 26 | Eisai LimitedINDUSTRY | 1 | Apr 13, 2012 | clinicaltrials |
| NCT00969410 | A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases | completed | Phase 1 | 19 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 12, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 30, 2012source: clinicaltrials